ArticleInternational journal of biological sciences2022

ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance.

Jiefeng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.